Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa

SA Journal of Oncology

 
 
Field Value
 
Title Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa
 
Creator Geldenhuys, Daleen Rapoport, Bernardo L. Fourie, Samuel Szpak, Waldemar M. Rodrigues, Sylvia Pirjol, Anca I. Harris, Jill Botha, Michiel Jonas, Natalie Nel, Monique Bouharati, Celia McMaster, Alicia
 
Subject — lanreotide Autogel; somatostatin analogues; neuroendocrine tumours; gastroenteropancreatic neuroendocrine tumours; oncology
Description Background: Neuroendocrine tumours are known to impact patients’ quality of life because of the symptoms caused by hypersecretion of serotonin and other peptides, in particular diarrhoea and flushing.Aim: The Q-SYMTU study was a prospective, observational registry that included 24 symptomatic patients with gastroenteropancreatic neuroendocrine tumours.Setting: Multiple oncology practices in South Africa.Method: Patients’ level of satisfaction was evaluated for a 6-month period from initiation of treatment with lanreotide Autogel.Results: The number of patients who had greater than 50% self-reported reduction in daily episodes of diarrhoea and flushing were 67% and 80%, respectively, over a 6-month period.Conclusion: Treatment with lanreotide Autogel was generally well tolerated, as demonstrated by low occurrence of Grade 3 and Grade 4 adverse events (AEs). None of the Grade 4 AEs were related to the study treatment. No Grade 5 AEs were reported.
 
Publisher AOSIS
 
Contributor Sanofi
Date 2020-10-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Observational Cohort Study
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajo.v4i0.138
 
Source South African Journal of Oncology; Vol 4 (2020); 7 pages 2523-0646 2518-8704
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajo.org.za/index.php/sajo/article/view/138/386 https://sajo.org.za/index.php/sajo/article/view/138/385 https://sajo.org.za/index.php/sajo/article/view/138/387 https://sajo.org.za/index.php/sajo/article/view/138/384
 
Coverage South Africa 2015-2018 >18 yrs; Neuroendocrine Patients
Rights Copyright (c) 2020 Daleen Geldenhuys, Bernardo L. Rapoport, Samuel Fourie, Waldemar M. Szpak, Sylvia Rodrigues, Anca I. Pirjol, Jill Harris, Michiel Botha, Natalie Jonas, Monique Nel, Celia Bouharati, Alicia McMaster https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT